When to Stop Colon Cancer Screening
Routine colorectal cancer screening should stop at age 75 in average-risk adults who are up-to-date with prior screening, or when life expectancy falls below 10 years, whichever comes first 1.
Age-Based Stopping Algorithm
Age 75 and Under
- Continue routine screening if life expectancy exceeds 10 years and patient is in good health 1
- This is the clear cutoff for average-risk individuals with negative prior screening results
Ages 76-85
The decision becomes individualized based on a structured assessment 1:
Consider selective screening only if:
- No prior screening history (never been screened)
- Good overall health status
- Life expectancy substantially exceeds 10 years
- Patient preference after informed discussion of limited benefits
Key factors to evaluate:
- Prior screening history (particularly if last colonoscopy was negative)
- Current comorbidities and functional status
- Patient values and preferences regarding screening burden
- Overall mortality risk versus potential screening benefit
The evidence indicates that the net benefit of screening in this age group is small, and the USPSTF assigns this a Grade C recommendation (selective offering) 1.
Age 86 and Older
Actively discourage screening 1. The overall mortality risk and adverse events from colonoscopy outweigh any potential life expectancy benefits at this age.
Critical Context: Prior Screening History Matters
If the patient had a negative high-quality colonoscopy:
- The threshold to stop screening at age 75 is stronger 1
- These individuals have demonstrated low colorectal cancer risk
- Continuing screening beyond 75 offers minimal additional benefit
If the patient has never been screened:
- Consider screening up to age 85 depending on health status and comorbidities 1
- This represents a qualified recommendation with low-quality evidence
- The rationale is that unscreened individuals may harbor undetected disease
Life Expectancy as a Stopping Criterion
Life expectancy less than 10 years = stop screening, regardless of age 1. This is because:
- The lag time between detecting precancerous lesions and preventing cancer typically exceeds 10 years
- Screening harms (procedural complications, false positives) outweigh benefits when life expectancy is limited
- Comorbidities that limit life expectancy also increase procedural risks
Consensus Across Guidelines
The 2022 U.S. Multi-Society Task Force, USPSTF, American College of Physicians, and American Cancer Society all converge on these stopping ages 1, 2. The most recent 2026 ACS update reaffirms stopping at age 75 for those with life expectancy greater than 10 years 3.
Common Pitfalls to Avoid
- Don't reflexively order screening colonoscopy in patients over 75 without assessing life expectancy and prior screening history
- Don't continue screening in patients with limited life expectancy just because they're under 75
- Don't screen anyone over 85 - the guidelines uniformly discourage this 1
- Don't forget to factor in procedural risks - older adults have higher complication rates from colonoscopy, including perforation and cardiovascular events